Global adoption of COVID-19 early treatments

100% 75% 50% 25% 0% COVID-19 EARLY TREATMENT EFFICACY DEC 2025 - SUBMIT UPDATES/CORRECTIONS - C19EARLY.ORG
$0 Non-mutagenic $2000+ $0 Mutagenic $2000+ COVID-19 EARLY TREATMENT COST DEC 2025 - SUBMIT UPDATES/CORRECTIONS - C19EARLY.ORG
Treatment
Improvement
  (early)
Studies
  (early)
AMAmubarv../r.. 91% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EVEnsovibep 89% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BHBromhexine 84% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MTMelatonin 78% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SPSpironolactone 77% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PHAlkalinization 76% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PXProxalutamide 71% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHXChlorhexidine 69% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MBMebendazole 68% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AAspirin 67% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RSVResveratrol 67% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STXSentinox 67% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OLGOlgotrelvir 67% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZLAzelastine 66% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(H)CQHydroxychlor.. 66% 38
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V.AVitamin A 62% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IVMIvermectin 61% 40
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V.DVitamin D 60% 11
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PIPovidone-Iod.. 60% 15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H1RAH1RA 56% 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPMChlorphenira.. 56% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RGRegdanvimab 54% 11
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BLBamlaniv../e.. 52% 15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MFMetformin 51% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BUBudesonide 49% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FMFamotidine 48% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FVFluvoxamine 48% 12
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CICasirivimab/i.. 47% 22
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ARTArtemisinin 47% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LFLactoferrin 47% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NSNigella Sativa 46% 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COColchicine 45% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AAAntiandrogen 44% 6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NONitric Oxide 44% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZnZinc 41% 6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APAndrograph.. 40% 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
V.CVitamin C 39% 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
XNXXiannuoxin 38% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPCCetylpyridin.. 37% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AZVAzvudine 36% 8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BTBebtelovimab 34% 6
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PBProbiotics 34% 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NFNafamostat 33% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
H2O2Hydrogen Per.. 33% 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
QQuercetin 32% 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NZNitazoxanide 29% 8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NCNiclosamide 29% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PTPhthalocyan.. 29% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCCurcumin 29% 12
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NACLNaCl 28% 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IBZIbuzatrelvir 27% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SSotrovimab 26% 25
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BFBemnifosbuvir 21% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TMPRSS2TMPRSS2 21% 11
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LRLeritrelvir 21% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NACN-acetylcys.. 19% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PLPaxlovid 18% 61
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FPVFavipiravir 18% 22
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PILPeg.. Lambda 17% 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SNSSNS812 17% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ENEnsitrelvir 14% 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ATLAtilotrelvir 13% 1
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VV116Deuremidevir 11% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MPMolnupiravir 9% 41
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CMCamostat 8% 8
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RDRemdesivir 2% 11
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICIota-carragee.. - 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DTDiet - 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SUNSunlight - 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PVPemivibart - 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PPIPPI - 0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ACEAcetaminophen -22% 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TCTixagev../c.. -29% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CPConv. Plasma -37% 7
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IBIbuprofen -52% 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Global adoption of early treatments. Studies, improvement, and adoption refer to early treatment only. Countries ordered by population. Official:
 
  High-profit:
 
  Increased risk:
 
  Unofficial:
 
References
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/*/https://twitter.com/Covid19Crusher/status/135404377252764876..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/*/https://twitter.com/Covid19Crusher/status/135403342454633676..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
https://web.archive.org/web/*/https://twitter.com/Covid19Crusher/status/138770936838954598..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/*/https://twitter.com/Covid19Crusher/status/128077261903439872..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/20200523223516/https://www.moh.gov.sa/Ministry/MediaCenter/Pub..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
https://web.archive.org/web/20200523223516/https://www.moh.gov.sa/Ministry/MediaCenter/Pub..
https://web.archive.org/web/20201027172422/https://www.moh.gov.sa/Ministry/MediaCenter/Pub..
https://web.archive.org/web/20210412200113/https://www.hsj.gr/medicine/is-there-a-correlat..
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)
(during pandemic, most mAbs are no longer recommended due to reduced efficacy with modern variants)